Treatment of irritable bowel syndrome with diarrhoea using titrated ondansetron (TRITON): study protocol for a randomised controlled trial
Author:
Funder
Efficacy and Mechanism Evaluation Programme
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Medicine (miscellaneous)
Link
http://link.springer.com/content/pdf/10.1186/s13063-019-3562-6.pdf
Reference33 articles.
1. Tillisch K, Labus JS, Naliboff BD, Bolus R, Shetzline M, Mayer EA, et al. Characterization of the alternating bowel habit subtype in patients with irritable bowel syndrome. Am J Gastroenterol. 2005;100(4):896–904 Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3865067 .
2. Atarodi S, Rafieian S, Whorwell PJ. Faecal incontinence-the hidden scourge of irritable bowel syndrome: a cross-sectional study. BMJ Open Gastroenterol. 2014;1(1):e000002 Available from: http://www.ncbi.nlm.nih.gov/pubmed/26462260 . [cited 2019 Feb 11].
3. Andresen V, Montori VM, Keller J, West CP, Layer P, Camilleri M. Effects of 5-hydroxytryptamine (serotonin) type 3 antagonists on symptom relief and constipation in nonconstipated irritable bowel syndrome: a systematic review and meta-analysis of randomized controlled trials. Clin Gastroenterol Hepatol. 2008;6(5):545–55 Available from: http://linkinghub.elsevier.com/retrieve/pii/S1542356507011573 . [cited 2018 Jun 28].
4. Fukudo S, Kinoshita Y, Okumura T, Ida M, Akiho H, Nakashima Y, et al. Ramosetron reduces symptoms of irritable bowel syndrome with diarrhea and improves quality of life in women. Gastroenterology. 2016;150(2):358–66 e8. Available from: https://linkinghub.elsevier.com/retrieve/pii/S001650851501584X . [cited 2019 Jun 28].
5. Fukudo S, Ida M, Akiho H, Nakashima Y, Matsueda K. Effect of ramosetron on stool consistency in male patients with irritable bowel syndrome with diarrhea. Clin Gastroenterol Hepatol. 2014;12(6):953–9 e4. Available from: https://linkinghub.elsevier.com/retrieve/pii/S1542356513018302 . [cited 2019 Jun 28].
Cited by 12 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Top 10 research priorities for irritable bowel syndrome: results of a James Lind Alliance priority setting partnership;The Lancet Gastroenterology & Hepatology;2023-06
2. Randomised, placebo‐controlled trial and meta‐analysis show benefit of ondansetron for irritable bowel syndrome with diarrhoea: The TRITON trial;Alimentary Pharmacology & Therapeutics;2023-03-03
3. Gastrointestinal Dysmotility in Critically Ill Patients;Journal of Clinical Gastroenterology;2022-10-10
4. Functional bowel disorders with diarrhoea: Clinical guidelines of the United European Gastroenterology and European Society for Neurogastroenterology and Motility;United European Gastroenterology Journal;2022-06-13
5. Emerging therapies in the management of Irritable Bowel Syndrome (IBS);Expert Opinion on Emerging Drugs;2022-01-02
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3